Vivos Therapeutics, Inc. (VVOS)

0.1489 0.00 (0.00%) USD  |  NASDAQ  |  Oct 09, 16:00
0.1461 0.00 (0.00%) After-Hours: 20:00
More

Vivos Therapeutics EPS Diluted (Quarterly) : -0.31 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.31
March 31, 2026 -0.5249
December 31, 2025 -0.7424
September 30, 2025 -0.4925
June 30, 2025 -0.5516
March 31, 2025 -0.4496
December 31, 2024 -0.48
September 30, 2024 -0.3955
June 30, 2024 -0.5978
March 31, 2024 -1.630
December 31, 2023 -2.322
September 30, 2023 -1.748
June 30, 2023 -4.618
March 31, 2023 -1.719
Date Value
December 31, 2022 -6.615
September 30, 2022 -6.398
June 30, 2022 -8.232
March 31, 2022 -6.277
December 31, 2021 -8.032
September 30, 2021 -6.546
June 30, 2021 -4.873
March 31, 2021 -4.666
December 31, 2020 -15.69
September 30, 2020 -2.835
March 31, 2020 -3.89
December 31, 2019 -3.954
September 30, 2019 -4.592

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Hinge Health, Inc. 0.5167
Exlites Holdings International, Inc. -0.0001
Xcelerate, Inc. -0.0001
Pro-Dex, Inc. 0.8672
Autonomix Medical, Inc. -5.018

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -5.523M
Revenue (Quarterly) 5.153M
Total Expenses (Quarterly) 10.63M
Enterprise Value 13.83M
Gross Profit Margin (Quarterly) 47.41%
Profit Margin (Quarterly) -107.2%
Earnings Yield -1.39K%
Normalized Earnings Yield -1398.05